226 related articles for article (PubMed ID: 17951026)
1. Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: implications for rheumatoid arthritis.
Gutiérrez-Cañas I; Juarranz Y; Santiago B; Martínez C; Gomariz RP; Pablos JL; Leceta J
Brain Behav Immun; 2008 Mar; 22(3):312-7. PubMed ID: 17951026
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of naive CD4+ T cells towards T helper 2 cells is not impaired in rheumatoid arthritis patients.
van Roon JA; Glaudemans CA; Bijlsma JW; Lafeber FP
Arthritis Res Ther; 2003; 5(5):R269-76. PubMed ID: 12932290
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells.
Juarranz MG; Santiago B; Torroba M; Gutierrez-Cañas I; Palao G; Galindo M; Abad C; Martinez C; Leceta J; Pablos JL; Gomariz RP
Rheumatology (Oxford); 2004 Apr; 43(4):416-22. PubMed ID: 14657510
[TBL] [Abstract][Full Text] [Related]
5. Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis.
Wahle M; Hanefeld G; Brunn S; Straub RH; Wagner U; Krause A; Häntzschel H; Baerwald CG
Arthritis Res Ther; 2006; 8(5):R138. PubMed ID: 16889669
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
[TBL] [Abstract][Full Text] [Related]
7. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis.
Delgado M; Toscano MG; Benabdellah K; Cobo M; O'Valle F; Gonzalez-Rey E; Martín F
Arthritis Rheum; 2008 Apr; 58(4):1026-37. PubMed ID: 18383372
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis.
Deng S; Xi Y; Wang H; Hao J; Niu X; Li W; Tao Y; Chen G
Cell Immunol; 2010; 265(2):105-10. PubMed ID: 20716449
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic effect of vasoactive intestinal peptide on experimental arthritis is associated with CD4+CD25+ T regulatory cells.
Chen G; Hao J; Xi Y; Wang W; Wang Z; Li N; Li W
Scand J Immunol; 2008 Dec; 68(6):572-8. PubMed ID: 19055696
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis.
Kokkonen H; Söderström I; Rocklöv J; Hallmans G; Lejon K; Rantapää Dahlqvist S
Arthritis Rheum; 2010 Feb; 62(2):383-91. PubMed ID: 20112361
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
12. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
Gonzalez-Rey E; Delgado M
Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease.
Delgado M; Abad C; Martinez C; Leceta J; Gomariz RP
Nat Med; 2001 May; 7(5):563-8. PubMed ID: 11329057
[TBL] [Abstract][Full Text] [Related]
14. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
15. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.
Juarranz Y; Gutiérrez-Cañas I; Santiago B; Carrión M; Pablos JL; Gomariz RP
Arthritis Rheum; 2008 Apr; 58(4):1086-95. PubMed ID: 18383383
[TBL] [Abstract][Full Text] [Related]
17. Intracytoplasmic Th1 and Th2 cytokines in rheumatoid arthritis blood and synovial tissue.
Bourg V; Portalès P; Fiorito S; Combe B; Jorgensen C; Sany J; Clot J
J Autoimmun; 1999 Dec; 13(4):415-22. PubMed ID: 10585757
[TBL] [Abstract][Full Text] [Related]
18. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
[TBL] [Abstract][Full Text] [Related]
19. Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis.
Mahendra A; Misra R; Aggarwal A
J Rheumatol; 2009 Aug; 36(8):1730-6. PubMed ID: 19531753
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
Gonzalez-Rey E; Chorny A; Varela N; O'Valle F; Delgado M
Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]